**Author details**

Linda Ding1 , Carla D. Bradford1 , Kenneth Ulin1 , Koren Smith1 , I-Lin Kuo1 , Yankhua Fan1 , Abdulnasser Khalifeh1 , Fenghong Liu1 , Suhong Lu1 , Harry Bushe1 , Salvatore Larosa1 , Camelia Bunaciu1 , Jonathan Saleeby1 , Shannon Higgins1 , Julie Trifone1 , Maureen Britton1 , Joshua Taylor1 , Marious Croos1 , Katie Figura1 , Thomas Quinn1 , Linda O'Connor1 , Kathleen Briggs1 , Sherri Suhl1 , Jean Quigley1 , Heather Reifler1 , Shawn Kirby1 , Fred Prior2 , Joel Saltz3 , Maryann Bishop-Jodoin1 and Thomas J. FitzGerald1 \*

1 Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA, USA

2 Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA

3 Department of Biomedical Informatics, Stony Brook School of Medicine, Stony Brook, NY, USA

\*Address all correspondence to: tj.fitzgerald@umassmemorial.org

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Clinical Considerations for Modern Dosimetry and Future Directions for Treatment Planning DOI: http://dx.doi.org/10.5772/intechopen.105910*
